S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

DAWN Day One Biopharmaceuticals Inc

14.70

-0.02 (-0.14%)

Pre Market

Last Updated: 08:03:35

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Day One Biopharmaceuticals (NASDAQ:DAWN)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Day One Biopharmaceuticals Charts.

Day One Biopharmaceuticals (NASDAQ:DAWN)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Day One Biopharmaceuticals Charts.

Day One Biopharmaceuticals Inc News

Form 144 - Report of proposed sale of securities
Thursday 31 October 2024 (17 hours ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 30 October 2024 (2 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 30 October 2024 (2 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 12 September 2024 (2 months ago) • Edgar (US Regulatory)

Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers
Wednesday 28 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 19 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 19 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Friday 16 August 2024 (3 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Friday 16 August 2024 (3 months ago) • Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Monday 5 August 2024 (3 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 2 August 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 30 July 2024 (3 months ago) • Edgar (US Regulatory)

More Day One Biopharmaceuticals Inc News Articles

Vontobel Financial Produ...

Exchange Traded

Vontobel Financial Produ...

Uber Technologies

Desjardins RI Emerg Mkts...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions